Explaining the variation in on-site AIDS treatment costs: the MATCH study of 161 facilities from five countries

Over, Mead; Schneider, Matthew T; Velayudhan, Tejaswi.
Lancet ; 381(suppl.2): S106-S106, 2013.
Artículo en Inglés | BVSCARGA, FIOCRUZ | ID: car-1105

Documentos relacionados

  1. Updated direct costs of medical care for HIV-infected patients within a regional population from 2006 to 2017.
  2. Financial burden of health care for HIV/AIDS patients in Vietnam.
  3. The impact of socioeconomic factors on the healthcare costs of people living with HIV in Turkey.
  4. Differentiated HIV care in sub-Saharan Africa: a scoping review to inform antiretroviral therapy provision for stable HIV-infected individuals in Kenya.
  5. Study: HAART less costly than treatment for AIDS. Annual health care cost lowered by 31%.
  6. Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
  7. A multicentre study of patient survival, disability, quality of life and cost of care: among patients with AIDS in northern Italy.
  8. The economics of artificial organs.
  9. Biotech's perfect storm.
  10. Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infection.